A Case Report in Using a Laboratory-Based Decision Support Alert for Research Enrollment and Randomization

Abstract

Objectives

Our objective was to identify barriers to implementing a custom clinical decision support (CDS) alert to randomize individuals in a pragmatic study, specifically those with a positive antinuclear antibody (ANA) test.

Methods

We integrated a validated logistic regression model into the electronic health record to predict the risk of developing autoimmune disease for individuals with a positive ANA (titer ≥ 1:80). A custom CDS alert was created to randomize eligible individuals into a pragmatic study evaluating whether the risk model reduces time to autoimmune disease diagnosis. The custom CDS alert runs silently in the background and is not visible to providers. Individuals were randomized to either an intervention or control arm. In the intervention arm, the study team reviewed risk model results, notified providers of high-risk scores, and offered expedited rheumatology referrals to high-risk individuals in addition to standard of care. The control arm received standard care only. The study team accessed a daily Epic report containing randomization assignments and model variables.

Results

Starting in June 2023, the risk model assessed 3,961 individuals and successfully randomized 2,105 individuals to date. Technical challenges that prevented the custom CDS alert from firing included an unanticipated change in the laboratory testing vendor and reporting due to a broken laboratory machine, followed by a change in the laboratory test name.

Conclusion

This case report showcases the successful implementation of a laboratory-based custom CDS alert to randomize individuals for a pragmatic study. This approach enabled our study to be feasible across a large health care system. Key lessons learned included the importance of close collaboration with the laboratory team and thorough understanding of the laboratory testing, workflow, and reporting to ensure successful execution of the laboratory-based custom CDS alert.

Keywords

electronic health records and systems - clinical decision support - implementation and deployment - clinical care - precision medicine

• References

• 1 Olsen NJ, Karp DR. Finding lupus in the ANA haystack. Lupus Sci Med 2020; 7 (01) e000384
• 2 Olsen NJ, Choi MY, Fritzler MJ. Emerging technologies in autoantibody testing for rheumatic diseases. Arthritis Res Ther 2017; 19 (01) 172
• 3 Pisetsky DS. Antinuclear antibody testing - misunderstood or misbegotten?. Nat Rev Rheumatol 2017; 13 (08) 495-502
• 4 Wandstrat AE, Carr-Johnson F, Branch V. et al. Autoantibody profiling to identify individuals at risk for systemic lupus erythematosus. J Autoimmun 2006; 27 (03) 153-160
• 5 Satoh M, Chan EK, Ho LA. et al. Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis Rheum 2012; 64 (07) 2319-2327
• 6 McGhee JL, Kickingbird LM, Jarvis JN. Clinical utility of antinuclear antibody tests in children. BMC Pediatr 2004; 4: 13
• 7 Correll CK, Ditmyer MM, Mehta J. et al. 2015 American College of Rheumatology workforce study and demand projections of pediatric rheumatology workforce, 2015-2030. Arthritis Care Res (Hoboken) 2022; 74 (03) 340-348
• 8 Battafarano DF, Ditmyer M, Bolster MB. et al. 2015 American College of Rheumatology workforce study: supply and demand projections of adult rheumatology workforce, 2015-2030. Arthritis Care Res (Hoboken) 2018; 70 (04) 617-626
• 9 Miloslavsky EM, Marston B. The challenge of addressing the rheumatology workforce shortage. J Rheumatol 2022; 49 (06) 555-557
• 10 Sebastiani GD, Prevete I, Iuliano A, Minisola G. The importance of an early diagnosis in systemic lupus erythematosus. Isr Med Assoc J 2016; 18 (3-4): 212-215
• 11 Sebastiani GD, Prevete I, Iuliano A. et al. Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onset. Lupus 2018; 27 (09) 1479-1488
• 12 Chen Z, Li MT, Xu D. et al. Organ damage in patients with incomplete lupus syndromes: from a Chinese academic center. Clin Rheumatol 2015; 34 (08) 1383-1389
• 13 Minier T, Guiducci S, Bellando-Randone S. et al; EUSTAR co-workers, EUSTAR co-workers. Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis. Ann Rheum Dis 2014; 73 (12) 2087-2093
• 14 Sloan M, Harwood R, Sutton S. et al. Medically explained symptoms: a mixed methods study of diagnostic, symptom and support experiences of patients with lupus and related systemic autoimmune diseases. Rheumatol Adv Pract 2020; 4 (01) rkaa006
• 15 Barnado A, Moore RP, Domenico HJ. et al. Identifying antinuclear antibody positive individuals at risk for developing systemic autoimmune disease: development and validation of a real-time risk model. Front Immunol 2024; 15: 1384229
• 16 Rees F, Doherty M, Lanyon P. et al. Early clinical features in systemic lupus erythematosus: can they be used to achieve earlier diagnosis? A risk prediction model. Arthritis Care Res (Hoboken) 2017; 69 (06) 833-841
• 17 Adamichou C, Genitsaridi I, Nikolopoulos D. et al. Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus. Ann Rheum Dis 2021; 80 (06) 758-766
• 18 Walker SC, Creech CB, Domenico HJ, French B, Byrne DW, Wheeler AP. A real-time risk-prediction model for pediatric venous thromboembolic events. Pediatrics 2021; 147 (06) e2020042325
• 19 Walker SC, French B, Moore R. et al. Use of a real-time risk-prediction model to identify pediatric patients at risk for thromboembolic events: study protocol for the Children's Likelihood Of Thrombosis (CLOT) trial. Trials 2022; 23 (01) 901
• 20 Walker SC, French B, Moore RP. et al. Model-guided decision-making for thromboprophylaxis and hospital-acquired thromboembolic events among hospitalized children and adolescents: the CLOT randomized clinical trial. JAMA Netw Open 2023; 6 (10) e2337789
• 21 Ende HB, Domenico HJ, Polic A. et al. Development and validation of an automated, real-time predictive model for postpartum hemorrhage. Obstet Gynecol 2024; 144 (01) 109-117
• 22 Yiadom MYAB, Domenico HJ, Byrne DW. et al. Impact of a follow-up telephone call program on 30-day readmissions (FUTR-30): a pragmatic randomized controlled real-world effectiveness trial. Med Care 2020; 58 (09) 785-792
• 23 Reese TJ, Domenico HJ, Hernandez A. et al. Implementable prediction of pressure injuries in hospitalized adults: model development and validation. JMIR Med Inform 2024; 12: e51842
• 24 Schisterman EF, Perkins NJ, Liu A, Bondell H. Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples. Epidemiology 2005; 16 (01) 73-81
• 25 Plombon S, S Rudin R, Sulca Flores J. et al. Assessing equitable recruitment in a digital health trial for asthma. Appl Clin Inform 2023; 14 (04) 620-631
• 26 Naceanceno KS, House SL, Asaro PV. Shared-task worklists improve clinical trial recruitment workflow in an academic emergency department. Appl Clin Inform 2021; 12 (02) 293-300
• 27 van der Zaag AY, Bhagirath SC, Boerman AW. et al. Appropriate use of blood cultures in the emergency department through machine learning (ABC): study protocol for a randomised controlled non-inferiority trial. BMJ Open 2024; 14 (05) e084053
• 28 Chen Y, Shah A, Jani Y. et al. Rationale and design of the THIRST Alert feasibility study: a pragmatic, single-centre, parallel-group randomised controlled trial of an interruptive alert for oral fluid restriction in patients treated with intravenous furosemide. BMJ Open 2024; 14 (01) e080410
• 29 Wilson FP, Martin M, Yamamoto Y. et al. Electronic health record alerts for acute kidney injury: multicenter, randomized clinical trial. BMJ 2021; 372: m4786